Department of Diagnostic & Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN 55455, USA.
Department of Diagnostic & Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN 55455, USA.
Bone. 2023 Jul;172:116759. doi: 10.1016/j.bone.2023.116759. Epub 2023 Apr 11.
Studies using kinase inhibitors have shown that the protein kinase D (PRKD) family of serine/threonine kinases are required for formation and function of osteoclasts in culture. However, the involvement of individual protein kinase D genes and their in vivo significance to skeletal dynamics remains unclear. In the current study we present data indicating that protein kinase D3 is the primary form of PRKD expressed in osteoclasts. We hypothesized that loss of PRKD3 would impair osteoclast formation, thereby decreasing bone resorption and increasing bone mass. Conditional knockout (cKO) of Prkd3 using a murine Cre/Lox system driven by cFms-Cre revealed that its loss in osteoclast-lineage cells reduced osteoclast differentiation and resorptive function in culture. Examination of the Prkd3 cKO mice showed that bone parameters were unaffected in the femur at 4 weeks of age, but consistent with our hypothesis, Prkd3 conditional knockout resulted in 18 % increased trabecular bone mass in male mice at 12 weeks and a similar increase at 6 months. These effects were not observed in female mice. As a further test of our hypothesis, we asked if Prkd3 cKO could protect against bone loss in a ligature-induced periodontal disease model but did not see any reduction in bone destruction in this system. Together, our data indicate that PRKD3 promotes osteoclastogenesis both in vitro and in vivo.
使用激酶抑制剂的研究表明,蛋白激酶 D(PRKD)家族丝氨酸/苏氨酸激酶对于培养中的破骨细胞的形成和功能是必需的。然而,个别蛋白激酶 D 基因的参与及其对骨骼动力学的体内意义尚不清楚。在本研究中,我们提供的数据表明,蛋白激酶 D3 是破骨细胞中表达的主要 PRKD 形式。我们假设 PRKD3 的缺失会损害破骨细胞的形成,从而减少骨吸收并增加骨量。使用由 cFms-Cre 驱动的小鼠 Cre/Lox 系统对 Prkd3 进行条件性敲除(cKO),结果表明其在破骨细胞谱系细胞中的缺失减少了培养中的破骨细胞分化和吸收功能。对 Prkd3 cKO 小鼠的检查表明,在 4 周龄时股骨的骨参数没有受到影响,但与我们的假设一致,Prkd3 条件性敲除导致 12 周龄雄性小鼠的小梁骨量增加了 18%,6 个月时也有类似的增加。在雌性小鼠中未观察到这些影响。作为对我们假设的进一步检验,我们询问 Prkd3 cKO 是否可以防止结扎诱导的牙周病模型中的骨丢失,但在该系统中未观察到骨破坏的减少。总之,我们的数据表明 PRKD3 可促进体外和体内的破骨细胞发生。